Core Viewpoint - Zhongyuan Securities has shown a positive stock performance with a 3.72% increase year-to-date and a market capitalization of 20.707 billion yuan as of January 6 [1] Group 1: Stock Performance - On January 6, Zhongyuan Securities' stock price increased by 2.06%, reaching 4.46 yuan per share, with a trading volume of 74.14 million yuan and a turnover rate of 0.49% [1] - The stock has experienced a 1.83% increase over the last five trading days and a 2.53% increase over the last 20 days, while it has decreased by 3.30% over the last 60 days [1] Group 2: Financial Performance - For the period from January to September 2025, Zhongyuan Securities reported an operating income of 1.439 billion yuan, representing a year-on-year growth of 11.38%, and a net profit attributable to shareholders of 389 million yuan, which is a significant increase of 138.68% year-on-year [2] Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders of Zhongyuan Securities was 119,300, a decrease of 1.00% from the previous period, while the average number of circulating shares per person increased by 1.01% to 28,918 shares [2] - The company has distributed a total of 1.509 billion yuan in dividends since its A-share listing, with 241 million yuan distributed in the last three years [3] - Among the top ten circulating shareholders, the Guotai Zhongzheng All-Index Securities Company ETF ranked fifth with 71.2405 million shares, an increase of 28.6494 million shares from the previous period, while the Huabao Zhongzheng All-Index Securities Company ETF entered as the ninth largest shareholder with 46.9325 million shares [3]

Market Overview - On January 5, the A-share market opened high and trended upward, with the Shanghai Composite Index finding support around 3984 points before stabilizing and rising[2][3] - The Shanghai Composite Index closed at 4023.42 points, up 1.38%, while the Shenzhen Component Index rose 2.24% to 13828.63 points[7][8] - Total trading volume for both markets reached 25,675 billion yuan, above the median of the past three years[3][16] Sector Performance - Strong performers included insurance, medical services, semiconductors, and electronic components, while tourism, aviation, robotics, and railways lagged[3][7] - Over 80% of stocks in the two markets rose, with notable gains in sectors like medical devices and shipbuilding[7][9] Valuation Metrics - The average price-to-earnings (P/E) ratios for the Shanghai Composite and ChiNext indices are 16.30 times and 49.98 times, respectively, above the median levels of the past three years, indicating a favorable long-term investment environment[3][16] Economic Outlook - The attractiveness of RMB assets is increasing, with expectations for credit growth and supportive policies in the new year[3][16] - The domestic monetary policy is expected to remain "moderately loose," while the market anticipates continued interest rate cuts by the Federal Reserve in 2026, contributing to a more favorable global liquidity environment[3][16] Investment Recommendations - Investors are advised to focus on sectors such as electronic components, semiconductors, insurance, and medical services for short-term opportunities[3][16]

Group 1 - The stock of Sifang New Materials (605122.SH) closed at 12.62 yuan, with a decline of 4.03% [1] - Sifang New Materials was listed on the Shanghai Stock Exchange on March 10, 2021, with an issuance of 30.90 million shares at a price of 42.88 yuan per share [1] - The highest price recorded for the stock since its listing was 61.75 yuan, indicating that the stock is currently in a state of decline [1] - The total amount raised from the initial public offering (IPO) was 1.32499 billion yuan, with a net amount of 1.23512 billion yuan after deducting issuance costs [1] - The funds raised were intended for projects including prefabricated concrete components, dry-mixed mortar, logistics upgrades, and working capital [1] - The total issuance costs for the IPO amounted to 89.869 million yuan, with underwriting fees accounting for 77.3269 million yuan [1] Group 2 - On May 27, 2021, Sifang New Materials distributed a cash dividend of 0.6 yuan per share (including tax) based on a total share capital of 123,110,000 shares prior to the distribution [2] - The company also increased its capital reserve by issuing 0.4 shares for every share held, resulting in a total distribution of 73.866 million yuan in cash dividends and 49.244 million shares being transferred [2] - Following this distribution, the total share capital increased to 172,354,000 shares [2]

Macro Dynamics - The Ministry of Commerce announced safeguard measures for imported beef, stating that an investigation was initiated on December 27, 2024, due to domestic industry requests. The measures include country-specific quotas and additional tariffs for three years, with annual quota increases to support the domestic industry [2] Financial Institutions - Major state-owned banks, including ICBC, ABC, CCB, BOC, and Postal Savings Bank, announced that starting January 1, 2026, interest will be paid on the balances of real-name digital RMB wallets at the same rate as current deposits. The announcement emphasizes the distinction between real-name and anonymous wallets, with specific interest rules applying only to real-name wallets [9] Market Data - The A-share market closed on December 31, 2025, with the Shanghai Composite Index rising 0.09% for a total annual increase of 18.41%, marking a ten-year high. The Shenzhen Component Index increased by 29.87% over the year, while the ChiNext Index saw a significant rise of 49.57% [11] - The Hong Kong stock market also reported strong performance, with the Hang Seng Index increasing by 27.77% for the year, the best annual performance since 2017. The Hang Seng Tech Index rose by 23.45%, marking its best annual performance since 2020 [12] Company Dynamics - The first domestically produced quadrivalent HPV vaccine has been launched, developed by China National Pharmaceutical Group. The vaccine covers four HPV types and has shown 100% efficacy in preventing certain precancerous lesions in clinical trials, providing a cost-effective option for women aged 18 to 45 [14] - Tianqi Materials announced an expected net profit increase of 127.31% to 230.63% for 2025, driven by rising demand in the new energy vehicle and energy storage markets, along with improved production efficiency [15] - Platinum Technology is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws, but the company stated that its operations remain normal [16] - Changan Ford announced a recall of 38,473 units of the Ford Focus due to compliance with regulations regarding defective automotive products [17]

海外監管公告 香港交易及結算所有限本公司及香港聯合交易所有限本公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產 生或因倚賴該等內容而引致之任何損失承擔任何責任。 本公告乃由中原證券股份有限公司（「本公司」）根據香港聯合交易所有限公司 證券上市規則第13.10B條作出。 茲載列本公司於上海證券交易所網站發佈之《中原證券股份有限公司第七屆董 事會第四十一次會議決議公告》《中原證券股份有限公司信息披露事務管理制度》 《中原證券股份有限公司投資者關係管理制度》，僅供參閱。 Central China Securities Co., Ltd. （2002年於中華人民共和國河南省成立的股份有限公司，中文公司名稱為「中原証券股份有限公司」， 在香港以「中州証券」名義開展業務） （股份代號：01375） 中原证券股份有限公司（以下简称"公司"）董事会及全体董事保证本公告 内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准 确性和完整性承担法律责任。 於本公告日期，本公司董事為張秋雲女士、李文強先生、馮若凡先生、唐進先生、田聖春先 生及朱軍紅 ...

Central China Securities Co., Ltd. （2002年於中華人民共和國河南省成立的股份有限公司，中文公司名稱為「中原証券股份有限公司」， 在香港以「中州証券」名義開展業務） （股份代號：01375） 董事會薪酬與提名委員會 工作規程 第一章 總則 第一條 為規範中原證券股份有限公司（以下簡稱「公司」）董事和高級管理 人員的提名、薪酬和考核制度，完善公司治理結構，根據《中華人民共和國公 司法》、《中華人民共和國證券法》、《證券公司監督管理條例》、《證券公司治 理準則》、《上市公司獨立董事管理辦法》、《上海證券交易所股票上市規則》、 《香港聯合交易所有限公司證券上市規則》（以下簡稱「香港上市規則」）等相關 法律法規、規範性文件及《中原證券股份有限公司章程》（以下簡稱「公司章程」）， 公司董事會設立董事會薪酬與提名委員會（以下簡稱「薪酬與提名委員會」）， 並制定本工作規程。 第二條 薪酬與提名委員會是公司董事會下設的專門機構，主要負責制定 公司董事及高級管理人員的考核標準並進行考核；負責制定、審查公司董事 及高級管理人員的薪酬政策與方案；對公司董事、高級管理人員的選任程序、 標準和任職資 ...

中州证券(01375)发布公告，公司董事会于2025年12月31日收到独立非执行董事曾崧先生的书面辞职报 告。由于工作原因，彼申请辞去公司第七届董事会独立非执行董事及董事会下属专门委员会委员职务。 ...

Central China Securities Co., Ltd. （2002年於中華人民共和國河南省成立的股份有限公司，中文公司名稱為「中原証券股份有限公司」， 在香港以「中州証券」名義開展業務） （股份代號：01375） 董事會薪酬與提名委員會 工作規程 第一章 總則 第一條 為規範中原證券股份有限公司（以下簡稱「公司」）董事和高級管理 人員的提名、薪酬和考核制度，完善公司治理結構，根據《中華人民共和國公 司法》、《中華人民共和國證券法》、《證券公司監督管理條例》、《證券公司治 理準則》、《上市公司獨立董事管理辦法》、《上海證券交易所股票上市規則》、 《香港聯合交易所有限公司證券上市規則》（以下簡稱「香港上市規則」）等相關 法律法規、規範性文件及《中原證券股份有限公司章程》（以下簡稱「公司章程」）， 公司董事會設立董事會薪酬與提名委員會（以下簡稱「薪酬與提名委員會」）， 並制定本工作規程。 第二條 薪酬與提名委員會是公司董事會下設的專門機構，主要負責制定 公司董事及高級管理人員的考核標準並進行考核；負責制定、審查公司董事 及高級管理人員的薪酬政策與方案；對公司董事、高級管理人員的選任程序、 標準和任職資 ...

格隆汇12月31日丨中州证券(01375.HK)发布公告，董事会于2025年12月31日收到独立非执行董事曾崧的 书面辞职报告。由于工作原因，彼申请辞去公司第七届董事会独立非执行董事及董事会下属专门委员会 委员职务。 ...

中原證券股份有限公司董事（「董事」）會（「董事會」）成員如下： Central China Securities Co., Ltd. （2002年於中華人民共和國河南省成立的股份有限公司，中文公司名稱為「中原証券股份有限公司」， 在香港以「中州証券」名義開展業務） （股份代號：01375） 董事名單及其角色和職能 執行董事 張秋雲女士 （董事長） 「C」 指有關委員會之召集人 「M」 指有關委員會之委員 陳志勇先生 王 輝先生 王慧軒先生 杜曉堂先生 – 1 – 董事會下設四個董事會專門委員會。各董事於該等委員會中擔任的職位載列 如下： | | 戰略與 | | | | | --- | --- | --- | --- | --- | | | 可持續發展 | 薪酬與提名 | 審計 | 風險控制 | | | 委員會 | 委員會 | 委員會 | 委員會 | | 張秋雲女士 | C | | | C | | 李文強先生 | M | | | | | 馮若凡先生 | M | | | M | | 唐 進先生 | M | | | | | 田聖春先生 | M | | | | | 朱軍紅女士 | | M | M | | | 陳志勇先 ...